Apyx Medical Q3 EPS $(0.13) Misses $(0.11) Estimate, Sales $11.98M Miss $15.37M Estimate
Portfolio Pulse from Benzinga Newsdesk
Apyx Medical's Q3 earnings per share (EPS) of $(0.13) missed the analyst consensus estimate of $(0.11) by 18.18%. The company's quarterly sales of $11.98 million also fell short of the analyst consensus estimate of $15.37 million by 22.08%. However, both EPS and sales showed an increase compared to the same period last year.
November 09, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Apyx Medical's Q3 earnings and sales missed estimates, which could negatively impact the stock in the short term.
Apyx Medical's Q3 earnings and sales fell short of analyst estimates, which is typically seen as a negative signal by the market and could lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100